Identifying immune cell changes in chronic lung diseases using advanced sequencing techniques.
Identifying Disease-Specific Immune Cell Shifts in Chronic Fibrotic Interstitial Lung Diseases with Single-Cell RNA Sequencing
This study is looking at how immune cells change in people with chronic lung diseases to find new ways to diagnose and treat conditions like idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis, using a simple blood test.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11017010 on NIH RePORTER |
What this research studies
This research investigates how immune cells change in patients with chronic fibrotic interstitial lung diseases (ILDs) by using a cutting-edge technique called single-cell RNA sequencing. The goal is to better understand the specific immune responses associated with different types of ILDs, which can help in making accurate diagnoses. By analyzing blood samples, the researchers aim to identify unique biomarkers that can distinguish between various forms of ILDs, such as idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. This minimally invasive approach could lead to improved diagnostic methods and tailored treatments for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic fibrotic interstitial lung diseases, particularly those experiencing symptoms related to these conditions.
Not a fit: Patients with acute lung conditions or those without a diagnosis of interstitial lung disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and better treatment options for patients with chronic fibrotic interstitial lung diseases.
How similar studies have performed: Previous research has shown promise in using single-cell RNA sequencing to identify immune cell changes in various diseases, indicating that this approach could be effective in the context of interstitial lung diseases as well.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Zhao, Amy Yue-Ting — Yale University
- Study coordinator: Zhao, Amy Yue-Ting
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.